Tumor resection fails to better survival in metastatic neuroblastoma

01/31/2013 | Healio

A study in the Journal of Clinical Oncology revealed that primary tumor resection did not improve the five-year, event-free survival in patients with metastatic neuroblastoma. The German researchers said the findings "do not justify aggressive surgery in patients undergoing high-intensity multimodal treatment for metastatic neuroblastoma."

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX